Literature DB >> 17230030

Mirtazapine enantiomers in blood and cerebrospinal fluid.

Pierre Baumann1, Michèle Jonzier-Perey, Erik Paus, Georg Nikisch.   

Abstract

Little information exists on the concentrations of recent antidepressants and their metabolites in cerebrospinal fluid (CSF). Using a stereoselective method, we measured plasma and CSF levels of mirtazapine (MIR), N-demethylmirtazapine and 8-OH-MIR in 3 depressed patients treated with racemic MIR (45 mg/day) for 4 weeks. S-(+)-MIR is considered to be the antidepressant enantiomer, but only R-(-)-MIR reached measurable concentrations in CSF. For R-(-)-MIR, the CSF/plasma ratio varied between 0.08 and 0.31. Further studies are needed to test the hypothesis that there are possible differences in the transport mechanisms of the enantiomers of MIR at the blood-CSF barrier. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17230030     DOI: 10.1159/000098654

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  Distribution pattern of mirtazapine and normirtazapine in blood and CSF.

Authors:  Michael Paulzen; Gerhard Gründer; Simone C Tauber; Tanja Veselinovic; Christoph Hiemke; Sarah E Groppe
Journal:  Psychopharmacology (Berl)       Date:  2014-08-23       Impact factor: 4.530

2.  Doxepin concentrations in plasma and cerebrospinal fluid.

Authors:  Robert Schomburg; Daniela Remane; Klaus Fassbender; Hans H Maurer; Jörg Spiegel
Journal:  J Neural Transm (Vienna)       Date:  2011-02-25       Impact factor: 3.575

3.  Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

Authors:  Anna-Britta Lind; Margareta Reis; Finn Bengtsson; Michele Jonzier-Perey; Kerry Powell Golay; Johan Ahlner; Pierre Baumann; Marja-Liisa Dahl
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.